Distributed Biomanufacturing Facilities of the Future

The future of healthcare depends on leveraging state-of-the-art advancements in biopharmaceutical manufacturing across the world. A near end-to-end distributed biomanufacturing setup will enable production to occur closer to points-of-care or points-of-need, thereby reducing lead times, improving adaptability to unseasonal demands and ensuring accessibility in rural and resource-limited settings. However, the current distributed biomanufacturing systems typically produce lower volumes compared to conventional facilities. This perspective discusses the present status of distributed biomanufacturing and envisions futuristic models on portable platforms providing high mobility and production capacity. This conceptual framework for deployable biomanufacturing could facilitate an impartial global distribution of biotherapeutics, improved pandemic preparedness, reduced production costs, provide medical tourism and even utilization in space exploration. By integrating advanced technologies such as continuous manufacturing, machine learning, sensors, and real-time process control, these platforms would enable rapid, agile, and efficient production of biologics. Furthermore, we discuss key considerations such as regulatory pathways, quality management systems and secure cloud-based data handling for one such mobile platform housed on a ship. This vision for distributed biomanufacturing aims to spark innovation and drive efforts toward the futuristic goal of providing affordable and high-quality biopharmaceuticals with equitable access around the world.